Pros | - | ![]() 3Y returns in the top 25% of the category. ![]() Larger AUM within category. | ||
Cons | - | - |
INDMoney rank | - | - | ||
Category,Subcateogry | Equity,Index Funds | Equity,Index Funds | ||
Fund Age | 0 Years | 4 Years | ||
Fund Size | 25 Cr | 8543 Cr | ||
Min Investment | SIP ₹500 Lumpsum ₹500 | SIP ₹500 Lumpsum ₹1000 | ||
Expense Ratio | 0.62% | 0.43% | ||
Exit Load | 1% | 0% | ||
Benchmark Index | Nifty MidSmall Healthcare Index (TRI) | Nifty200 Momentum 30 TR INR |
No of Holdings | 32 | 32 | ||
Top 5 Holdings | Max Healthcare Institute Ltd Ordinary Shares (15.01%) Lupin Ltd (8.49%) Fortis Healthcare Ltd (6.6%) Aurobindo Pharma Ltd (5.76%) Mankind Pharma Ltd (5%) | Bharti Airtel Ltd (6.18%) Mahindra & Mahindra Ltd (5.33%) Divi's Laboratories Ltd (5.31%) Bharat Electronics Ltd (5.29%) BSE Ltd (5.06%) | ||
No of Sectors | 1 | 9 | ||
Top 3 Sectors | Health (100%) | Tech (28.92%) Consumer Cyclical (24.36%) Health (14.07%) | ||
Equity % | 99.67% | 99.93% | ||
Debt % | - | - | ||
P/E | 40.58 | 39.87 | ||
P/B | 5.8 | 7.31 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 2.96% | -2.2% | ||
3-Month Return | 10.89% | 15.29% | ||
6-Month Return | 2.54% | -1.01% | ||
1-Year Return | - | -14.81% | ||
3-Year Return | - | 23.21% | ||
5-Year Return | - | - |
Sharpe | - | 1 | ||
Alpha | - | -0.15 | ||
Beta | - | 1 | ||
Standard Deviation | - | 18.31 | ||
Information Ratio | - | -1.18 |
Description | Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | UTI Nifty200 Momentum 30 Index Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Swapnil Mayekar | Sharwan Kumar Goyal |